AstraZeneca / Oxford vacancy against covid-19 has “limited efficacy” ante variante sudafricana

The British evacuation unveiled by AstraZeneca / Oxford has not been tested against the live demonstrations of Covid-19 taking place in the South African variant, but could be found in front of the graves, indicating that Domingo Sarah Gilbert, Oxford University investigator

Agreed to AstraZeneca’s Portfolio, quoted the quarrels by the Financial Times, a study on a sample of 2,000 demonstrators that the British vaccine has “a limited efficacy over the life forms caused by the South African variant”.

However, it may be necessary to have serious forms of nursing, although there are no sufficient dates on this study, which will be published on Monday, as to be confirmed definitively.

The South African variant, the product of Oxford / AstraZeneca “does not reduce the total number of cases, but can also protect against death, hospitalizations and more serious forms of illness”, it is domino to the BBC Gilbert, who lead the development of this vacancy.

Without embarrassment, “llevar un tiempo” will have antes to determine its efficacy against the new variant, which is more frequent among seniors in the United Kingdom, added.

.Source